MARKET

FMS

FMS

Fresenius Care
NYSE

Real-time Quotes | Nasdaq Last Sale

40.36
+1.10
+2.80%
After Hours: 39.97 -0.39 -0.97% 16:00 05/13 EDT
OPEN
40.19
PREV CLOSE
39.26
HIGH
40.41
LOW
40.11
VOLUME
211.23K
TURNOVER
--
52 WEEK HIGH
46.55
52 WEEK LOW
31.50
MARKET CAP
23.64B
P/E (TTM)
17.76
1D
5D
1M
3M
1Y
5Y
Fiduciary Management Inc Buys Fresenius Medical Care AG. ...
GuruFocus News · 13h ago
15 European Dividend Aristocrats To Diversify Your Portfolio
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that have proven to reward shareholders with rising dividends over a long period.
Benzinga · 1d ago
swisspartners Advisors Ltd Buys Stellantis NV, ArcelorMittal SA, ABB, Sells Consumer ...
GuruFocus News · 1d ago
Fresenius Medical (FMS) Gains 1.1% Since Q1 Earnings Beat
Fresenius Medical's (FMS) first-quarter earnings benefit from organic growth in Health Care Products segment, and performance in Asia Pacific.
Zacks · 1d ago
Fresenius Medical Care's International Campaign Recognizes Nurses at the Center of Healthcare
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced an international campaign that recognizes and supports the organization's nurses and clinical teams throughout Asia Pacific, ...
BusinessWire · 2d ago
Tweedy Browne Adds Fresenius, Progressive to Portfolio
GuruFocus.com · 3d ago
--Credit Suisse Raises Price Target on Fresenius Medical Care to EUR68 From EUR62, Maintains Neutral Rating
MT Newswires · 3d ago
Research Alert: CFRA Lower Opinion On Adss Of Fresenius Medical Care To Hold From Buy
MT Newswires · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FMS. Analyze the recent business situations of Fresenius Care through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FMS stock price target is 38.81 with a high estimate of 45.82 and a low estimate of 36.66.
EPS
Institutional Holdings
Institutions: 271
Institutional Holdings: 11.37M
% Owned: 1.94%
Shares Outstanding: 585.78M
TypeInstitutionsShares
Increased
51
493.05K
New
22
1.88M
Decreased
43
496.91K
Sold Out
19
443.10K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.23%
Healthcare Providers & Services
+0.45%
Key Executives
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Corporate Executive
Harry De Wit
Vice President - Research & Development/Management Board
Olaf Schermeier
Management Board
Harry de Wit
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Management Board
Kent Wanzek
Independent Director/Supervisory Board
William Johnston
Supervisory Board
Deborah McWhinney
Independent Director/Supervisory Board
Dorothea Wenzel
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zund
Supervisory Board
Gregor Zuend
Declaration Date
Dividend Per Share
Ex-Div Date
08/12/2020
Dividend USD 0.497802
08/28/2020
05/08/2019
Dividend USD 0.450194
05/17/2019
05/10/2018
Dividend USD 0.427
05/21/2018
05/17/2017
Dividend USD 0.37
05/11/2017
05/16/2016
Dividend USD 0.313
05/10/2016
05/21/2015
Dividend USD 0.298
05/15/2015
05/19/2014
Dividend USD 0.368
05/13/2014
05/20/2013
Dividend USD 0.334
05/14/2013
  • All
  • Financials
  • Insiders
More
About FMS
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Webull offers kinds of Fresenius Medical Care AG & Co. KGaA stock information, including NYSE:FMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FMS stock methods without spending real money on the virtual paper trading platform.